Pascal Loyer Selected Research

Pascal Loyer Research Topics

Disease

18	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 09/2003
13	Neoplasms (Cancer) 01/2023 - 09/2003
3	Iron Overload 04/2004 - 01/2002
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Gout 02/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2019
1	Alcoholic Fatty Liver 02/2019
1	Inflammation (Inflammations) 02/2019
1	Hypertrophy 01/2018
1	Cachexia 11/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Wounds and Injuries (Trauma) 01/2012
1	Hypoxia (Hypoxemia) 11/2009
1	Colorectal Neoplasms (Colorectal Cancer) 08/2009
1	Colonic Neoplasms (Colon Cancer) 08/2009
1	Hemochromatosis (Bronze Diabetes) 07/2003
1	Liver Failure 12/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2013
4	Peptides (Polypeptides)IBA 06/2022 - 10/2013
4	poly(malic acid)IBA 04/2021 - 02/2012
4	EnzymesIBA 05/2019 - 11/2009
3	poly(benzyl malate)IBA 04/2022 - 02/2012
3	Biotin (Vitamin H)FDA Link 04/2022 - 02/2012
3	Ethanol (Ethyl Alcohol)IBA 08/2020 - 11/2009
3	XenobioticsIBA 05/2019 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2017 - 02/2012
3	IronIBA 04/2004 - 01/2002
2	LipidsIBA 12/2022 - 11/2009
2	Liposomes (Liposome)IBA 12/2022 - 05/2017
2	StreptavidinIBA 04/2022 - 10/2013
2	LigandsIBA 04/2022 - 02/2012
1	Phosphotransferases (Kinase)IBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	tau Proteins (tau Protein)IBA 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	maleimideIBA 06/2022
1	ApolipoproteinsIBA 04/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 04/2022
1	CyclinsIBA 11/2020
1	Gallium-68IBA 09/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2020
1	Technetium-99IBA 09/2020
1	Copper-64IBA 09/2020
1	Indium-111IBA 09/2020
1	Fluorine-18IBA 09/2020
1	AcidsIBA 07/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	CytokinesIBA 01/2020
1	SmokeIBA 01/2020
1	InflammasomesIBA 02/2019
1	Purinergic P2X7 ReceptorsIBA 02/2019
1	Purinergic Receptors (Receptors, Purine)IBA 02/2019
1	macro aggregates of albuminIBA 01/2018
1	mahuang-tangIBA 01/2018
1	GalactosamineIBA 07/2017
1	ProdrugsIBA 07/2017
1	erucylphosphocholineIBA 05/2017
1	polytrimethylene carbonateIBA 11/2016
1	cardiolipin synthetaseIBA 04/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	Cardiolipins (Cardiolipin)IBA 11/2015
1	cyclic arginine-glycine-aspartic acid peptideIBA 10/2013
1	biotin receptorIBA 10/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 02/2012
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 11/2010
1	Cytochrome P-450 CYP3AIBA 11/2009
1	Testosterone (Sustanon)FDA Link 11/2009
1	Oxygen (Dioxygen)IBA 11/2009
1	Amino Acids FDA Link 11/2009
1	dimethylethylsilylimidazoleIBA 11/2009
1	CytochromesIBA 11/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2009
1	Cytotoxins (Cytolysins)IBA 11/2009
1	Fluorouracil (Carac)FDA LinkGeneric 08/2009
1	Multidrug Resistance-Associated ProteinsIBA 08/2009
1	CD226 antigenIBA 05/2009
1	DeferiproneIBA 04/2004
1	Chelating AgentsIBA 04/2004
1	theasinensin AIBA 09/2003
1	trichostatin A (A 300)IBA 09/2003
1	Caspase 3 (Caspase-3)IBA 12/2002
1	CaspasesIBA 12/2002
1	Caspase 8 (Caspase-8)IBA 12/2002
1	Thioacetamide (Thioacetamid)IBA 12/2002
1	Protein Isoforms (Isoforms)IBA 01/2002

Therapy/Procedure

6	Therapeutics 01/2023 - 09/2003
1	Precision Medicine 04/2021
1	Microspheres (Microsphere) 01/2018
1	Hepatectomy 01/2015
1	Drug Therapy (Chemotherapy) 11/2009